Found: 22
Select item for more details and to access through your institution.
Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 6, p. 472, doi. 10.1002/cpdd.117
- By:
- Publication type:
- Article
The effect of maraviroc on the pharmacokinetics of digoxin in healthy volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 3, p. 202, doi. 10.1002/cpdd.91
- By:
- Publication type:
- Article
Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2639, doi. 10.1007/s11095-023-03564-3
- By:
- Publication type:
- Article
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01120
- By:
- Publication type:
- Article
Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 5, p. 768, doi. 10.1111/j.1365-2125.2011.04136.x
- By:
- Publication type:
- Article
Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1058, doi. 10.1002/cpt.2829
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling for Ceftazidime‐Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and Older.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 182, doi. 10.1002/cpt.2764
- By:
- Publication type:
- Article
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 665, doi. 10.1002/cpt.2594
- By:
- Publication type:
- Article
Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 605, doi. 10.1002/cpt.2593
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 635, doi. 10.1002/cpt.2460
- By:
- Publication type:
- Article
Leveraging Human Plasma‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Cytochrome P450 3A4 by Modafinil.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 425, doi. 10.1002/cpt.2440
- By:
- Publication type:
- Article
Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 404, doi. 10.1002/cpt.2434
- By:
- Publication type:
- Article
Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 507, doi. 10.1002/cpt.2022
- By:
- Publication type:
- Article
Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 201, doi. 10.1002/cpt.1857
- By:
- Publication type:
- Article
Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 1004, doi. 10.1002/cpt.1695
- By:
- Publication type:
- Article
The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1567, doi. 10.1007/s00228-012-1287-5
- By:
- Publication type:
- Article
Mechanisms of Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Ritonavir-Enhanced Tipranavir.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 6, p. 888, doi. 10.1592/phco.27.6.888
- By:
- Publication type:
- Article
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as Probes.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 7, p. 784, doi. 10.1002/jcph.2215
- By:
- Publication type:
- Article
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 1, p. 139, doi. 10.1002/jcph.1306
- By:
- Publication type:
- Article
Study of the ketohexokinase inhibitor PF‐06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 1, p. 1, doi. 10.1111/cts.13644
- By:
- Publication type:
- Article
A literature review of liver function test elevations in rifampin drug–drug interaction studies.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 7, p. 1561, doi. 10.1111/cts.13281
- By:
- Publication type:
- Article